Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
World Journal of Nuclear Medicine|February 24, 2021
<sup>18</sup>F-prostate-specific membrane antigen positron emission tomography computed tomography incidental finding in a patient after COVID-19 infectionSiroos Mirzaei, Cherin Farhan, Mario Karolyi
Wiener Klinische Wochenschrift|May 28, 2021
Flavonifractor plautii bloodstream infection in an asplenic patient with infectious colitisIzabella Karpat, Mario Karolyi, Erich Pawelka, et al.
Wiener Klinische Wochenschrift|June 17, 2024
The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patientsMoritz Platzer, David Totschnig, Mario Karolyi, et al.
Wiener Klinische Wochenschrift|January 9, 2019
Hypoalbuminemia as predictor of recurrence of Clostridium difficile infectionDaniela Knafl, Matthias G Vossen, Christian Gerges, et al.
Viruses|May 27, 2023
Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19Victoria Kauer, David Totschnig, Ferdinand Waldenberger, et al.
Microbiology Spectrum|June 13, 2022
Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19Tamara Seitz, Johannes Holbik, Julian Hind, et al.
Viruses|December 23, 2022
The Role of Bacterial and Fungal Superinfection in Critical COVID-19Tamara Seitz, Johannes Holbik, Alexander Grieb, et al.
Infection|June 17, 2019
Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18E Pawelka, Mario Karolyi, S Daller, et al.
Wiener Klinische Wochenschrift|June 20, 2019
Is there a clinical difference between influenza A and B virus infections in hospitalized patients? : Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018Mario Karolyi, Erich Pawelka, Simon Daller, et al.
The Journal of Infectious Diseases|May 31, 2020
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid TestsMarianna Traugott, Stephan Walter Aberle, Judith Helene Aberle, et al.
Pageof 5